REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
6.20
-0.15 (-2.36%)
May 26, 2026, 10:03 AM EDT - Market open
REGENXBIO Market Cap
REGENXBIO has a market cap or net worth of $320.53 million as of May 26, 2026. Its market cap has decreased by -10.49% in one year.
Market Cap
320.53M
Enterprise Value
426.18M
1-Year Change
-10.49%
Ranking
Category
Stock Price
$6.20
Market Cap Chart
Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $320.53M, a decrease of -57.22%. That is a compound annual growth rate of -7.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 328.30M | -54.97% |
| Dec 31, 2025 | 729.00M | 90.34% |
| Dec 31, 2024 | 383.00M | -51.50% |
| Dec 29, 2023 | 789.70M | -19.57% |
| Dec 30, 2022 | 981.90M | -29.79% |
| Dec 31, 2021 | 1.40B | -17.57% |
| Dec 31, 2020 | 1.70B | 12.32% |
| Dec 31, 2019 | 1.51B | 0.48% |
| Dec 31, 2018 | 1.50B | 45.18% |
| Dec 29, 2017 | 1.04B | 110.87% |
| Dec 30, 2016 | 491.10M | 12.43% |
| Dec 31, 2015 | 436.80M | -41.71% |
| Sep 17, 2015 | 749.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fennec Pharmaceuticals | 344.94M |
| Rezolute | 339.52M |
| Neumora Therapeutics | 337.97M |
| YD Bio | 334.02M |
| Palisade Bio | 326.48M |
| Lineage Cell Therapeutics | 324.09M |
| Invivyd | 324.07M |
| Rocket Pharmaceuticals | 323.21M |